Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors

NCT03061305 is registered in ClinicalTrials.gov with Strata Oncology as lead sponsor.

NCT NCT03061305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03061305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Trial Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Lead sponsor
Strata Oncology
Phase
Observational
Overall status
Terminated
Start date
November 30, 2016
Completion date
June 27, 2024
Enrollment
58,213 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

adult solid tumor, cancer, lymphoma, multiple myeloma